data13F

SPRY – Ars Pharmaceuticals Inc

Held by 2 of 60 tracked investors in their latest 13F filing · 1 counted on Most owned (narrow-view filings excluded)

Investors holding2
Combined shares1,045,895
Combined reported value$4.5M

SPRY chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Daniel Loeb 0.10 1,000,000$4.3MQ3 2026
Paul Tudor Jones narrow view 0.00 45,895$198KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view New45,8950.00
Q1 2026Daniel Loeb Added 79.8%1,000,0000.17
Q4 2025Daniel Loeb New556,2370.09

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view New45,8950.00
Q1 2026Daniel Loeb Added 79.8%1,000,0000.17
Q4 2025Daniel Loeb New556,2370.09

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

2 peakQ3 2026: 2 tracked investors
Q3 2024: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 2 tracked investorsQ3 2026: 2 tracked investors
20242026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Daniel Loeb1.00M1.00M1.00M556.2K––––
Paul Tudor Jones45.9K45.9K––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).